Luka Peternel

490 total citations
21 papers, 376 citations indexed

About

Luka Peternel is a scholar working on Pharmaceutical Science, Molecular Biology and Hematology. According to data from OpenAlex, Luka Peternel has authored 21 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmaceutical Science, 5 papers in Molecular Biology and 4 papers in Hematology. Recurrent topics in Luka Peternel's work include Drug Solubulity and Delivery Systems (7 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Mast cells and histamine (3 papers). Luka Peternel is often cited by papers focused on Drug Solubulity and Delivery Systems (7 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Mast cells and histamine (3 papers). Luka Peternel collaborates with scholars based in Slovenia, Japan and Australia. Luka Peternel's co-authors include Katja Kristan, Tea Lanišnik Rižner, Eva Lasič, Mateja Erdani Kreft, Urška Dragin Jerman, U. Urleb, Miha Kotnik, Igor Legen, Marko Anderluh and Gorazd Drevenšek and has published in prestigious journals such as International Journal of Pharmaceutics, European Journal of Pharmacology and Pharmaceutical Research.

In The Last Decade

Luka Peternel

21 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luka Peternel Slovenia 11 123 100 86 47 42 21 376
Alaa S. Tulbah Saudi Arabia 14 134 1.1× 137 1.4× 96 1.1× 24 0.5× 43 1.0× 30 384
Ágnes Rusznyák Hungary 10 124 1.0× 121 1.2× 24 0.3× 25 0.5× 51 1.2× 20 409
Abderrazzak Bentaher France 11 46 0.4× 156 1.6× 83 1.0× 25 0.5× 32 0.8× 22 514
Indrani Maji India 12 137 1.1× 104 1.0× 30 0.3× 20 0.4× 81 1.9× 30 376
Harsha Jain India 13 129 1.0× 85 0.8× 48 0.6× 15 0.3× 19 0.5× 27 367
Minki Lee South Korea 10 68 0.6× 112 1.1× 122 1.4× 80 1.7× 58 1.4× 23 460
Lina Yin China 11 95 0.8× 138 1.4× 35 0.4× 27 0.6× 15 0.4× 21 311
Hirokazu Katayama Japan 12 84 0.7× 109 1.1× 55 0.6× 44 0.9× 31 0.7× 30 398
Elena Lagreca Italy 10 144 1.2× 101 1.0× 25 0.3× 42 0.9× 110 2.6× 21 440
Katherine Shea United States 11 33 0.3× 63 0.6× 53 0.6× 37 0.8× 34 0.8× 26 297

Countries citing papers authored by Luka Peternel

Since Specialization
Citations

This map shows the geographic impact of Luka Peternel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luka Peternel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luka Peternel more than expected).

Fields of papers citing papers by Luka Peternel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luka Peternel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luka Peternel. The network helps show where Luka Peternel may publish in the future.

Co-authorship network of co-authors of Luka Peternel

This figure shows the co-authorship network connecting the top 25 collaborators of Luka Peternel. A scholar is included among the top collaborators of Luka Peternel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luka Peternel. Luka Peternel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Horvat, Matej, Alan Bizjak, Odon Planinšek, et al.. (2019). Elucidating molecular properties of kappa-carrageenan as critical material attributes contributing to drug dissolution from pellets with a multivariate approach. International Journal of Pharmaceutics. 566. 662–673. 11 indexed citations
2.
Horvat, Matej, et al.. (2015). High-throughput automated dissolution method applicable for a wide dose range of controlled release pellets. Drug Development and Industrial Pharmacy. 42(7). 1149–1157. 5 indexed citations
3.
Legen, Igor, Luka Peternel, Bertil Abrahamsson, et al.. (2015). Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Levetiracetam. Journal of Pharmaceutical Sciences. 104(9). 2676–2687. 19 indexed citations
4.
Kreft, Mateja Erdani, Urška Dragin Jerman, Eva Lasič, et al.. (2014). The characterization of the human cell line Calu-3 under different culture conditions and its use as an optimized in vitro model to investigate bronchial epithelial function. European Journal of Pharmaceutical Sciences. 69. 1–9. 117 indexed citations
5.
Kreft, Mateja Erdani, Urška Dragin Jerman, Eva Lasič, et al.. (2014). The Characterization of the Human Nasal Epithelial Cell Line RPMI 2650 Under Different Culture Conditions and Their Optimization for an Appropriate in vitro Nasal Model. Pharmaceutical Research. 32(2). 665–679. 74 indexed citations
6.
Urleb, U., et al.. (2013). Evaluation of the light scattering and the turbidity microtiter plate-based methods for the detection of the excipient-mediated drug precipitation inhibition. European Journal of Pharmaceutics and Biopharmaceutics. 85(3). 1148–1156. 5 indexed citations
7.
Kocjan, Darko, et al.. (2013). Hydroxypropyl Methylcellulose Mediated Precipitation Inhibition of Sirolimus: From a Screening Campaign to a Proof-of-Concept Human Study. Molecular Pharmaceutics. 10(6). 2299–2310. 14 indexed citations
8.
Urleb, U., et al.. (2012). Evaluation of a High-Throughput Screening Method for the Detection of the Excipient-Mediated Precipitation Inhibition of Poorly Soluble Drugs. Assay and Drug Development Technologies. 11(2). 117–129. 9 indexed citations
9.
Peternel, Luka, et al.. (2012). Suitability of Isolated Rat Jejunum Model for Demonstration of Complete Absorption in Humans for BCS-Based Biowaiver Request. Journal of Pharmaceutical Sciences. 101(4). 1436–1449. 19 indexed citations
10.
Peternel, Luka, et al.. (2012). Reduced intravenous toxicity of amiodarone nanosuspension in mice and rats. Drug and Chemical Toxicology. 36(3). 263–269. 13 indexed citations
11.
Peternel, Luka, et al.. (2011). Preparation and Characterization of Tablet Formulation based on Solid Dispersion of Glimepiride and Poly(ester amide) Hyperbranched Polymer. Pharmaceutical Development and Technology. 18(2). 323–332. 12 indexed citations
12.
Cegnar, Mateja, et al.. (2010). Toward Effective Long-Term Prevention of Thromboembolism: Novel Oral Anticoagulant Delivery Systems. Seminars in Thrombosis and Hemostasis. 36(1). 113–122. 4 indexed citations
13.
Peternel, Luka, et al.. (2009). Comparison of 3 Cytotoxicity Screening Assays and Their Application to the Selection of Novel Antibacterial Hits. SLAS DISCOVERY. 14(2). 142–150. 19 indexed citations
14.
Mijovski, Mojca Božič, et al.. (2009). Effect of replacement fluids saline, gelofusine, and blood on biochemical and hematological parameters in rats subjected to repeated blood sampling.. PubMed. 15(10). BR293–300. 3 indexed citations
15.
Zega, Anamarija, Aleš Obreza, Marko Oblak, et al.. (2006). Direct thrombin inhibitors built on the azaphenylalanine scaffold provoke degranulation of mast cells. Thrombosis and Haemostasis. 95(2). 294–300. 4 indexed citations
16.
Peternel, Luka, et al.. (2006). Inhibition of mast cell degranulation-induced drop of blood pressure with clemastine, cromolyn and compound 48/80 pretreatment. Inflammation Research. 55(S1). S07–S08. 2 indexed citations
17.
Anderluh, Marko, et al.. (2006). Recent Advances in Serine Protease Inhibitors as Anticoagulant Agents. Current Pharmaceutical Design. 13(3). 287–312. 17 indexed citations
18.
Zorko, Matjaž, et al.. (2006). Histamine release, an undesired effect of thrombin inhibitors with basic character, is mediated through direct activation of Gi proteins. European Journal of Pharmacology. 538(1-3). 182–187. 2 indexed citations
19.
Stegnar, Mojca, Gorazd Drevenšek, Mojca Božič Mijovski, et al.. (2005). Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models. Thrombosis and Haemostasis. 93(3). 437–442. 5 indexed citations
20.
Peternel, Luka, et al.. (2004). Evaluation of two experimental venous thrombosis models in the rat. Thrombosis Research. 115(6). 527–534. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alaa S. Tulbah Breakdown of academic impact, for papers by Ágnes Rusznyák Breakdown of academic impact, for papers by Abderrazzak Bentaher Breakdown of academic impact, for papers by Indrani Maji Breakdown of academic impact, for papers by Harsha Jain Breakdown of academic impact, for papers by Minki Lee Breakdown of academic impact, for papers by Lina Yin Breakdown of academic impact, for papers by Hirokazu Katayama Breakdown of academic impact, for papers by Elena Lagreca Breakdown of academic impact, for papers by Katherine Shea
Rankless by CCL
2026